FOCL
EDAP TMS S.A. American Depositary Shares
FOCL lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
FOCL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Healthy |
FOCL's balance sheet is currently healthy, but its revenue, profitability and cash flow are under pressure.
FOCL PE Valuation
FOCL has no meaningful PE right now: it lost money over the past year.
FOCL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect FOCL's losses to shrink, with revenue declining.
FOCL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.98 | -$0.39 |
| Q2 2024 | -$0.58 | -$0.07 |
| Q1 2024 | -$0.54 | -$0.23 |
| Q4 2023 | -$0.63 | -$0.55 |
| Q3 2023 | -$0.63 | -673% |
| Q2 2023 | -$0.51 | -738% |
| Q1 2023 | -$0.31 | -3200% |
| Q4 2022 | -$0.08 | -500% |
FOCL lost $0.98 per share over the past year, a bigger loss than the year before.
FOCL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.8M | -39% |
| Q2 2026 | $13.2M | -27% |
| Q1 2026 | $17.8M | +25% |
| Q4 2025 | $21.9M | +0.9% |
| Q2 2025 | $18.2M | +7% |
| Q1 2025 | $14.3M | -12% |
| Q4 2024 | $21.7M | +2.8% |
| Q2 2024 | $17M | +9.4% |
FOCL's revenue is shrinking: $10M last quarter, down 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -79% | -44 points |
| Q2 2026 | -61% | -25 points |
| Q1 2026 | -41% | +2.9 points |
| Q4 2025 | -28% | -9.1 points |
| Q3 2025 | -35% | N/A |
| Q2 2025 | -36% | +3 points |
| Q1 2025 | -44% | -12 points |
| Q4 2024 | -18% | -0.6 points |
FOCL's operating margin was −79% last quarter, down 44 points from the same quarter a year ago, near the bottom of its range since 2015.
FOCL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4M | +$891.5K |
| Q2 2026 | -$3.7M | +$2.4M |
| Q1 2026 | -$3M | +$3.7M |
| Q4 2025 | -$4.1M | -$3.4M |
| Q3 2025 | -$4.9M | +$1.6M |
| Q2 2025 | -$6.1M | +$1.4M |
| Q1 2025 | -$6.6M | -$1.4M |
| Q4 2024 | -$642.7K | +$1.4M |
FOCL has burned cash in most quarters: −$15M over the past year, against −$18M the year before.
FOCL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -12.2x | Net Cash |
| Q2 2022 | -13.3x | Net Cash |
| Q1 2022 | -85.7x | Net Cash |
| Q4 2021 | -148.8x | Net Cash |
| Q3 2021 | -49.2x | Net Cash |
| Q2 2021 | -27.7x | Net Cash |
FOCL has more cash than debt.
FOCL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 4.9 | Oversold |
FOCL's weekly RSI is 38 (neutral) and its Stochastic is 5 (oversold).
FOCL PE vs Healthcare Sector
| Metric | FOCL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
FOCL has no meaningful PE right now: it lost money over the past year.
FOCL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.03 | 15% below |
| 20 week MA | $4.62 | 26% below |
| 50 week MA | $4.20 | 19% below |
| 100 week MA | $3.12 | 9.3% above |
| 200 week MA | $4.98 | 32% below |
FOCL's trend is mixed: it's above one of its five weekly moving averages, and 32% below its 200-week average.
FOCL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.40 | $5.08 | +15% |
| 2021 | $5.08 | $5.65 | +11% |
| 2022 | $5.65 | $10.5 | +86% |
| 2023 | $10.5 | $5.28 | -50% |
| 2024 | $5.28 | $2.17 | -59% |
| 2025 | $2.17 | $3.40 | +57% |
| 2026 YTD | $3.40 | $3.41 | +0.3% |
FOCL has finished higher in four of the last six years, two of them by more than 50%. It's roughly flat so far in 2026.